Bacteriophage-nanocomposites

An easy and reproducible method for the construction, handling, storage and transport of conjugates for deployment of bacteriophages active against Pseudomonas aeruginosa

Ian R. Cooper, Matthew Illsley, Alina V. Korobeinyk, Raymond L D Whitby

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The purpose of this work was proof of concept to develop a novel, cost effective protocol for the binding of bacteriophages to a surface without loss of function, after storage in various media. The technology platform involved covalently bonding bacteriophage 13 (a Pseudomonas aeruginosa bacteriophage) to two magnetised multiwalled carbon nanotube scaffolds using a series of buffers; bacteriophage-nanotube (B-N) conjugates were efficacious after storage at 20. °C for six weeks. B-N conjugates were added to human cell culture in vitro for 9. days without causing necrosis and apoptosis. B-N conjugates were frozen (- 20. °C) in cell culture media for several weeks, after which recovery from the human cell culture medium was possible using a simple magnetic separation technique. The retention of viral infective potential was demonstrated by subsequent spread plating onto lawns of susceptible P. aeruginosa. Analysis of the human cell culture medium revealed the production of interleukins by the human fibroblasts upon exposure to the bacteriophage. One day after exposure, IL-8 levels transitorily increased between 60 and 100. pg/mL, but this level was not found on any subsequent days, suggesting an initial but not long lasting response. This paper outlines the development of a method to deliver antimicrobial activity to a surface that is small enough to be combined with other materials. To our knowledge at time of publication, this is the first report of magnetically coupled bacteriophages specific to human pathogens which can be recovered from test systems, and could represent a novel means to conditionally deploy antibacterial agents into living eukaryotic systems without the risks of some antibiotic therapies.

Original languageEnglish
Pages (from-to)111-118
Number of pages8
JournalJournal of Microbiological Methods
Volume111
DOIs
Publication statusPublished - Apr 1 2015
Externally publishedYes

Fingerprint

Nanocomposites
Bacteriophages
Pseudomonas aeruginosa
Nanotubes
Cell Culture Techniques
Culture Media
Pseudomonas Phages
Anti-Bacterial Agents
Carbon Nanotubes
Interleukins
Interleukin-8
Publications
Buffers
Necrosis
Fibroblasts
Apoptosis
Technology
Costs and Cost Analysis

Keywords

  • Bacteriophage
  • Cell culture
  • Cost-effective
  • Human
  • Nanotube

ASJC Scopus subject areas

  • Microbiology
  • Molecular Biology
  • Microbiology (medical)
  • Medicine(all)

Cite this

Bacteriophage-nanocomposites : An easy and reproducible method for the construction, handling, storage and transport of conjugates for deployment of bacteriophages active against Pseudomonas aeruginosa. / Cooper, Ian R.; Illsley, Matthew; Korobeinyk, Alina V.; Whitby, Raymond L D.

In: Journal of Microbiological Methods, Vol. 111, 01.04.2015, p. 111-118.

Research output: Contribution to journalArticle

@article{2412de312210417e9e00013ae46761f6,
title = "Bacteriophage-nanocomposites: An easy and reproducible method for the construction, handling, storage and transport of conjugates for deployment of bacteriophages active against Pseudomonas aeruginosa",
abstract = "The purpose of this work was proof of concept to develop a novel, cost effective protocol for the binding of bacteriophages to a surface without loss of function, after storage in various media. The technology platform involved covalently bonding bacteriophage 13 (a Pseudomonas aeruginosa bacteriophage) to two magnetised multiwalled carbon nanotube scaffolds using a series of buffers; bacteriophage-nanotube (B-N) conjugates were efficacious after storage at 20. °C for six weeks. B-N conjugates were added to human cell culture in vitro for 9. days without causing necrosis and apoptosis. B-N conjugates were frozen (- 20. °C) in cell culture media for several weeks, after which recovery from the human cell culture medium was possible using a simple magnetic separation technique. The retention of viral infective potential was demonstrated by subsequent spread plating onto lawns of susceptible P. aeruginosa. Analysis of the human cell culture medium revealed the production of interleukins by the human fibroblasts upon exposure to the bacteriophage. One day after exposure, IL-8 levels transitorily increased between 60 and 100. pg/mL, but this level was not found on any subsequent days, suggesting an initial but not long lasting response. This paper outlines the development of a method to deliver antimicrobial activity to a surface that is small enough to be combined with other materials. To our knowledge at time of publication, this is the first report of magnetically coupled bacteriophages specific to human pathogens which can be recovered from test systems, and could represent a novel means to conditionally deploy antibacterial agents into living eukaryotic systems without the risks of some antibiotic therapies.",
keywords = "Bacteriophage, Cell culture, Cost-effective, Human, Nanotube",
author = "Cooper, {Ian R.} and Matthew Illsley and Korobeinyk, {Alina V.} and Whitby, {Raymond L D}",
year = "2015",
month = "4",
day = "1",
doi = "10.1016/j.mimet.2015.02.005",
language = "English",
volume = "111",
pages = "111--118",
journal = "Journal of Microbiological Methods",
issn = "0167-7012",
publisher = "Elsevier",

}

TY - JOUR

T1 - Bacteriophage-nanocomposites

T2 - An easy and reproducible method for the construction, handling, storage and transport of conjugates for deployment of bacteriophages active against Pseudomonas aeruginosa

AU - Cooper, Ian R.

AU - Illsley, Matthew

AU - Korobeinyk, Alina V.

AU - Whitby, Raymond L D

PY - 2015/4/1

Y1 - 2015/4/1

N2 - The purpose of this work was proof of concept to develop a novel, cost effective protocol for the binding of bacteriophages to a surface without loss of function, after storage in various media. The technology platform involved covalently bonding bacteriophage 13 (a Pseudomonas aeruginosa bacteriophage) to two magnetised multiwalled carbon nanotube scaffolds using a series of buffers; bacteriophage-nanotube (B-N) conjugates were efficacious after storage at 20. °C for six weeks. B-N conjugates were added to human cell culture in vitro for 9. days without causing necrosis and apoptosis. B-N conjugates were frozen (- 20. °C) in cell culture media for several weeks, after which recovery from the human cell culture medium was possible using a simple magnetic separation technique. The retention of viral infective potential was demonstrated by subsequent spread plating onto lawns of susceptible P. aeruginosa. Analysis of the human cell culture medium revealed the production of interleukins by the human fibroblasts upon exposure to the bacteriophage. One day after exposure, IL-8 levels transitorily increased between 60 and 100. pg/mL, but this level was not found on any subsequent days, suggesting an initial but not long lasting response. This paper outlines the development of a method to deliver antimicrobial activity to a surface that is small enough to be combined with other materials. To our knowledge at time of publication, this is the first report of magnetically coupled bacteriophages specific to human pathogens which can be recovered from test systems, and could represent a novel means to conditionally deploy antibacterial agents into living eukaryotic systems without the risks of some antibiotic therapies.

AB - The purpose of this work was proof of concept to develop a novel, cost effective protocol for the binding of bacteriophages to a surface without loss of function, after storage in various media. The technology platform involved covalently bonding bacteriophage 13 (a Pseudomonas aeruginosa bacteriophage) to two magnetised multiwalled carbon nanotube scaffolds using a series of buffers; bacteriophage-nanotube (B-N) conjugates were efficacious after storage at 20. °C for six weeks. B-N conjugates were added to human cell culture in vitro for 9. days without causing necrosis and apoptosis. B-N conjugates were frozen (- 20. °C) in cell culture media for several weeks, after which recovery from the human cell culture medium was possible using a simple magnetic separation technique. The retention of viral infective potential was demonstrated by subsequent spread plating onto lawns of susceptible P. aeruginosa. Analysis of the human cell culture medium revealed the production of interleukins by the human fibroblasts upon exposure to the bacteriophage. One day after exposure, IL-8 levels transitorily increased between 60 and 100. pg/mL, but this level was not found on any subsequent days, suggesting an initial but not long lasting response. This paper outlines the development of a method to deliver antimicrobial activity to a surface that is small enough to be combined with other materials. To our knowledge at time of publication, this is the first report of magnetically coupled bacteriophages specific to human pathogens which can be recovered from test systems, and could represent a novel means to conditionally deploy antibacterial agents into living eukaryotic systems without the risks of some antibiotic therapies.

KW - Bacteriophage

KW - Cell culture

KW - Cost-effective

KW - Human

KW - Nanotube

UR - http://www.scopus.com/inward/record.url?scp=84923555420&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84923555420&partnerID=8YFLogxK

U2 - 10.1016/j.mimet.2015.02.005

DO - 10.1016/j.mimet.2015.02.005

M3 - Article

VL - 111

SP - 111

EP - 118

JO - Journal of Microbiological Methods

JF - Journal of Microbiological Methods

SN - 0167-7012

ER -